Uterine Fibroids Treatments
Find Uterine Fibroids Treatments
Brand Name
Hydroxyprogesterone
View Brand InformationFDA approval date: May 09, 2019
Classification: Progestin
Form: Injection
What is Hydroxyprogesterone?
Hydroxyprogesterone Caproate Injection, USP is indicated in non-pregnant women: for the treatment of advanced adenocarcinoma of the uterine corpus ; in the management of amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer; as a test for endogenous estrogen production and for the production of secretory endometrium and desquamation.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment